Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm

NCT00397670 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: Drug: BufferGel® with diaphragm

Sponsor

ReProtect Inc

Collaborators

[object Object]
[object Object]